AXGN
HOLD / NEUTRALMeanRevComposite
48.90
Technical
65.00
Fundamental
43.60
Rank
—
Price
41.37
Hurst
0.15
As of
Jul 30, 2026
Daily
Axogen, Inc.
HealthcareMedical DevicesAxogen develops and sells medical products for treating peripheral nerve injuries worldwide. Its product portfolio includes nerve grafts made from donated human tissue, surgical connectors and protective wraps for nerve repair, and soft tissue matrices derived from animal and human sources. The company supplies these devices to hospitals and surgical centers through distributors, primarily serving plastic surgeons, orthopedic specialists, and hand surgeons.
Market cap
$2.7B
P/E (trailing)
—
P/E (forward)
66.11
PEG ratio
99.04
Dividend yield
—
Beta
1.16
52w range
15.27 – 52.91
Return on equity
-18.21%
Profit margin
-13.36%
Revenue growth
+23.10%
Earnings growth
—
Price history
1Y: 45.29 (+162.4%) · range 15.59–51.73
Cycle position
42/ 100 cycle scoreMID-BULL
ENTRYAPPROACHMID-BULLNEAR-TOPEXIT
entry readiness 39 · WEAK SETUP · exit proximity 0
Conviction
27/ 100 · maturity 100%
VScore.403
Buildup.2049
EMA entry setup.2539
Fundamentals.1544
Volume profile
POC
43.52
Price vs POC
+4.1%
Overhead supply
20%
Runway
open sky
Value area 38.25–46.04 · 20% of 120d volume overhead · clean runway
Contributing sources
No source detections in the last 21 days.
Forward returns
| Horizon | Return | MFE | State |
|---|---|---|---|
| 20d | +25.10% | +25.10% | mature |
| 40d | +1.96% | +25.10% | 30/40d |